Skip to main content
Full details on Adverse event reporting can be found at the bottom of the page

Secondary Navigation Menu

  • Click Here for Prescribing Information and Adverse Event Reporting

To visit the global (BRAND) website, please choose from the options below:

  • HCP
  • Patient
Sign in as Healthcare Professional
Verquvo Verquvo
  • How does Verquvo
    work?
  • Verquvo
    data
  • Which patients are
    suitable for Verquvo?
  • How is Verquvo
    prescribed?
  • Resources
  • How does Verquvo
    work?
  • Verquvo
    data
  • Which patients are
    suitable for Verquvo?
  • How is Verquvo
    prescribed?
  • Resources
  • Country select
    • Country 1
    • Country 2
  • Click Here for Prescribing Information and Adverse Event Reporting
  • Sign in as Healthcare Professional
Bayer Bayer

Click here for Prescribing information and Adverse event reporting, further details on adverse event reporting can be found at the bottom of the page

Breadcrumb
  1. Home
  2. Resources

Discover a range of
professional resources
designed for prescribers
working with heart failure
patients

Resources

Verquvo Patient Information Booklet

Verquvo Patient Information Booklet

Verquvo Patient Information Booklet

Read more
Verquvo Patient Information Booklet Verquvo Patient Information Booklet

Verquvo Patient Information Leaflet

Verquvo Patient Information Leaflet

Verquvo Patient Information Leaflet

Read more
Verquvo Patient Information Leaflet Verquvo Patient Information Leaflet

Verquvo Prescribing Information

Verquvo Prescribing Information

Verquvo Prescribing Information

Read more
Verquvo Prescribing Information Verquvo Prescribing Information

Verquvo 2.5mg SmPC

Verquvo 2.5mg SmPC

Verquvo 2.5mg SmPC

Read more
Verquvo 2.5mg SmPC Verquvo 2.5mg SmPC

Verquvo 5mg SmPC

Verquvo 5mg SmPC

Verquvo 5mg SmPC

Read more
Verquvo 5mg SmPC Verquvo 5mg SmPC

Verquvo 10mg SmPC

Verquvo 10mg SmPC

Verquvo 10mg SmPC

Read more
Verquvo 10mg SmPC Verquvo 10mg SmPC

PP-VER-GB-0030 | November 2022

Reporting adverse events and quality complaints

▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information.

 

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Bayer plc.

 

If you want to report an adverse event or quality complaint, reports can be directed to: Tel: 0118 206 3500 or Email: pvuk@bayer.com

 

Further information is available on the "contact" tab at www.bayer.co.uk.

 

 

Bayer Bayer
  • Home
  • Which patients are
    suitable for Verquvo?
  • How does Verquvo
    work?
  • How is Verquvo
    prescribed?
  • Verquvo
    data
  • Resources
  • Privacy policy
  • Conditions of Use
  • Imprint
  • Report a Side Effect
  • Full Prescribing Information
  • Cookie Settings
  • Sitemap
  • Contact us
Bayer Bayer
  • Home
  • Which patients are
    suitable for Verquvo?
  • How does Verquvo
    work?
  • How is Verquvo
    prescribed?
  • Verquvo
    data
  • Resources
  • Privacy policy
  • Conditions of Use
  • Imprint
  • Report a Side Effect
  • Full Prescribing Information
  • Cookie Settings
  • Sitemap
  • Contact us

© 2023 Bayer plc

This website contains information on Verquvo® (vericiguat) which is based on the Summary of Product Characteristics (SmPC). Intended for UK audience only.

  • PP-VER-GB-0028 November 2022
hidden link for autofocus
Cookie consent image